These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38282234)

  • 1. Examining the impact of androgen deprivation therapy, masculine self-esteem, and psychological flexibility on distress and quality of life in men with prostate cancer.
    Chowdhury E; Horrocks T; McAteer G; Gillanders D
    Psychooncology; 2024 Jan; 33(1):e6277. PubMed ID: 38282234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hegemonic masculine ideals on self-esteem in prostate cancer patients undergoing androgen deprivation therapy (ADT) compared to ADT-naïve patients.
    Gentili C; McClean S; McGeagh L; Bahl A; Persad R; Harcourt D
    Psychooncology; 2022 Nov; 31(11):1958-1971. PubMed ID: 35833603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the role of psychological flexibility, masculine self-esteem and stoicism as predictors of psychological distress and quality of life in men living with prostate cancer.
    McAteer G; Gillanders D
    Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13097. PubMed ID: 31140670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
    Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
    Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.
    Benedict C; Traeger L; Dahn JR; Antoni M; Zhou ES; Bustillo N; Penedo FJ
    J Sex Med; 2014 Oct; 11(10):2571-80. PubMed ID: 25059094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
    Siebert AL; Lapping-Carr L; Morgans AK
    Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
    Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
    J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials.
    Sciarra A; Abrahamsson PA; Brausi M; Galsky M; Mottet N; Sartor O; Tammela TL; Calais da Silva F
    Eur Urol; 2013 Nov; 64(5):722-30. PubMed ID: 23628492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
    Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
    Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2-year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer.
    Garland SN; Savard J; Eisel SL; Wassersug RJ; Rockwood NJ; Thoms J; Jim HSL; Gonzalez BD
    Cancer; 2021 Dec; 127(24):4656-4664. PubMed ID: 34411294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
    Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
    Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
    Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
    Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
    Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
    Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.
    MacLennan S; Azevedo N; Duncan E; Dunsmore J; Fullwood L; Lumen N; Plass K; Ribal MJ; Roobol MJ; Nieboer D; Schouten N; Skolarus TA; Smith EJ; N'Dow J; Mottet N; Briganti A;
    Eur Urol; 2023 May; 83(5):393-401. PubMed ID: 36639296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management.
    Alwhaibi A; Alsanea S; Almadi B; Al-Sabhan J; Alosaimi FD
    Aging Male; 2022 Dec; 25(1):101-124. PubMed ID: 35343371
    [No Abstract]   [Full Text] [Related]  

  • 18. Androgen deprivation therapy's impact on the mood of prostate cancer patients as perceived by patients and the partners of patients.
    Van Dam D; Wassersug RJ; Hamilton LD
    Psychooncology; 2016 Jul; 25(7):848-56. PubMed ID: 26332203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in prostate cancer patients taking androgen deprivation therapy.
    Dacal K; Sereika SM; Greenspan SL
    J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer.
    Morgans AK; Chen YH; Sweeney CJ; Jarrard DF; Plimack ER; Gartrell BA; Carducci MA; Hussain M; Garcia JA; Cella D; DiPaola RS; Patrick-Miller LJ
    J Clin Oncol; 2018 Apr; 36(11):1088-1095. PubMed ID: 29522362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.